Corteva Acquires Symborg

Sustainable Agro Solutions Acquires Ceres Biotics

January 30, 2026

Agriculture

Sustainable Agro Solutions (SAS Group), a portfolio company of Stirling Square Capital Partners, has acquired Spain-based Ceres Biotics to expand its microbial biosolutions product portfolio and R&D capabilities. The deal strengthens SAS Group's presence in Europe and adds more than 550 proprietary microbial strains; financial terms were not disclosed.

Rovensa Acquires Agro-K

December 5, 2023

Agriculture

Rovensa Group has acquired Agro-K, a family-owned U.S. biostimulants developer founded in 1976 and based in Minneapolis. Agro-K will be integrated into Rovensa Next to strengthen Rovensa's biosolutions portfolio and accelerate its expansion in the United States; financial terms were not disclosed.

Biobest Group Acquires BioWorks, Inc.

July 10, 2023

Agriculture

Biobest Group has completed its acquisition of BioWorks, Inc., a Victor, New York-based manufacturer and marketer of biopesticides. The deal expands Biobest's biopesticide portfolio and establishes BioWorks' Victor facility as the group's North American manufacturing and marketing hub for biopesticides.

Corteva Acquires Stoller Group

November 30, 2022

Agriculture

Corteva, Inc. signed a definitive agreement to acquire Houston-based Stoller Group, a leading independent biologicals and plant-health company with operations in more than 60 countries and forecasted 2022 revenues of over $400 million. Corteva will pay $1.2 billion in cash (≈12x expected 2022 EBITDA); the deal is expected to close in the first half of 2023 and is intended to accelerate and expand Corteva’s Biologicals capabilities and commercial reach.

Grupo Fertiberia Acquires Trichodex

July 12, 2022

Agriculture

Grupo Fertiberia, a Triton Partners-backed leader in EU crop nutrition, has acquired Seville-based biotechnology company Trichodex to expand its biofertilisers, biostimulants and microorganism-based biocontrol capabilities. The deal strengthens Grupo Fertiberia's R&D and manufacturing footprint in sustainable crop nutrition and advances its Net Zero and product-decarbonisation strategy.

Servier Acquires Symphogen A/S from Novo Holdings and Other Owners

April 3, 2020

Biotechnology

Servier has acquired 100% of the share capital of Symphogen A/S from Novo Holdings and the remaining owners, taking ownership of the Danish therapeutic antibody discovery and early biologics development company. The deal brings Symphogen’s antibody discovery platform and CMC biologics development capabilities into Servier’s oncology and immuno-oncology R&D efforts to strengthen its biologics pipeline and development capacity.